ESR1 and neoplasm: In this context, is it intriguing to speculate that the emergence of the ERα36 splicing variant may impair FOXA/ERα dual regulation of estrogen target genes and, consequently, be implicated in liver carcinogenesis and/or tumor progression (see Figure 8).